John Sweetenham, MD, PhD

Editorials by John Sweetenham, MD

Editorial

Conflict management and data integrity in the shadows

HemOnc Today, November 10, 2018
John Sweetenham, MD
Consistent with the spirit of the Physician Payments Sunshine Act, the issue of financial conflicts of interest in the oncology domain has been…
Editorial

‘Insuring’ better outcomes

HemOnc Today, October 10, 2018
John Sweetenham, MD
In the last couple months, I have seen two young patients in my lymphoma clinic for whom insurance issues have had a significant effect on their…
Editorial

Cost-effectiveness and common sense

HemOnc Today, September 10, 2018
John Sweetenham, MD
Big-picture trends from ASCO’s most recent clinical practice survey — published in July with 2017 data — reflect ongoing…
Editorial

Natural language processing and the practice of hematology/oncology

HemOnc Today, August 10, 2018
John Sweetenham, MD
I will be in clinic the morning after I write this. Like most Tuesday mornings, I have a full schedule and need to stay close to being on time, given…
Editorial

Cancer clinical trials: Not suitable for prime time

HemOnc Today, July 10, 2018
John Sweetenham, MD
I am now very definitely within the demographic for those who watch prime-time TV. The best indicator of this is, of course, not the programming, but…
Editorial

Delivering on the promise of precision oncology

HemOnc Today, June 10, 2018
John Sweetenham, MD
The concept of genome-driven oncology became a reality almost 20 years ago with the introduction of imatinib, targeted to the ABL kinase. Even…
Editorial

Online oncology: Building (dis)connections

HemOnc Today, May 10, 2018
John Sweetenham, MD
The online resources available to us and to our patients to enhance cancer care are expanding at a dizzying rate. Leveraging digital technology…
Editorial

Clinical pathways: A new target

HemOnc Today, April 10, 2018
John Sweetenham, MD
It is now widely accepted that adherence to evidence-based clinical pathways for cancer treatment has the potential to reduce variability, improve…
Editorial

A sad week

HemOnc Today, March 10, 2018
John Sweetenham, MD
On February 2, Jon Huntsman Sr., the founder of Huntsman Cancer Institute at The University of Utah, passed away peacefully at home. Many tributes…
Editorial

Don’t give up the day job

HemOnc Today, February 10, 2018
John Sweetenham, MD
Anyone who has been reading the peer-reviewed oncology literature or publications like HemOnc Today will be familiar with the increasing problem of…